FilingReader Intelligence
Oncoinvent shareholders approve BerGenBio merger
August 4, 2025 at 02:01 PM UTC•By FilingReader AI
Oncoinvent ASA shareholders approved the merger plan with BerGenBio ASA at an extraordinary general meeting. The decision, supported by 36.9% of Oncoinvent's share capital, greenlights the merger where Oncoinvent shareholders will receive 1.2027 shares in BerGenBio for each Oncoinvent share.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
OSL:ONCIN•Oslo Stock Exchange
News Alerts
Get instant email alerts when Oncoinvent ASA publishes news
Free account required • Unsubscribe anytime